117 related articles for article (PubMed ID: 9387291)
1. [Anti-tumor activity and immune responses induced by human cancer-associated mucin core peptide].
Ma Y; Yuan M; Fei L
Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):419-21. PubMed ID: 9387291
[TBL] [Abstract][Full Text] [Related]
2. Relationship of pancreatic cancer apomucin to mammary and intestinal apomucins.
Byrd JC; Ho JJ; Lamport DT; Ho SB; Siddiki B; Huang J; Yan PS; Kim YS
Cancer Res; 1991 Feb; 51(3):1026-33. PubMed ID: 1988113
[TBL] [Abstract][Full Text] [Related]
3. Multiple forms of intracellular and secreted mucins in a pancreatic cancer cell line.
Ho JJ; Bi N; Siddiki B; Chung YS; Yuan M; Kim YS
Cancer Res; 1993 Feb; 53(4):884-90. PubMed ID: 7679052
[TBL] [Abstract][Full Text] [Related]
4. Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients.
Kotera Y; Fontenot JD; Pecher G; Metzgar RS; Finn OJ
Cancer Res; 1994 Jun; 54(11):2856-60. PubMed ID: 7514493
[TBL] [Abstract][Full Text] [Related]
5. Mucin synthesis and secretion in various human epithelial cancer cell lines that express the MUC-1 mucin gene.
Dahiya R; Kwak KS; Byrd JC; Ho S; Yoon WH; Kim YS
Cancer Res; 1993 Mar; 53(6):1437-43. PubMed ID: 8443822
[TBL] [Abstract][Full Text] [Related]
6. Polypeptide core of a human pancreatic tumor mucin antigen.
Lan MS; Hollingsworth MA; Metzgar RS
Cancer Res; 1990 May; 50(10):2997-3001. PubMed ID: 2334903
[TBL] [Abstract][Full Text] [Related]
7. A short synthetic peptide (DTRPAP) induces anti-mucin (MUC-1) antibody, which is reactive with human ovarian and breast cancer cells.
Avichezer D; Taylor-Papadimitriou J; Arnon R
Cancer Biochem Biophys; 1998 Jun; 16(1-2):113-28. PubMed ID: 9923971
[TBL] [Abstract][Full Text] [Related]
8. Characterization of new pancreatic cancer-reactive monoclonal antibodies directed against purified mucin.
Ho JJ; Bi N; Yan PS; Yuan M; Norton KA; Kim YS
Cancer Res; 1991 Jan; 51(1):372-80. PubMed ID: 1703039
[TBL] [Abstract][Full Text] [Related]
9. Association of sialyl-Lewis(a) and sialyl-Lewis(x) with MUC-1 apomucin ina pancreatic cancer cell line.
Ho JJ; Siddiki B; Kim YS
Cancer Res; 1995 Aug; 55(16):3659-63. PubMed ID: 7627976
[TBL] [Abstract][Full Text] [Related]
10. A phase I trial of a synthetic mucin peptide vaccine. Induction of specific immune reactivity in patients with adenocarcinoma.
Goydos JS; Elder E; Whiteside TL; Finn OJ; Lotze MT
J Surg Res; 1996 Jun; 63(1):298-304. PubMed ID: 8667619
[TBL] [Abstract][Full Text] [Related]
11. DU-PAN-2, mucin type differentiation antigen of normal and malignant pancreatic ductal cells.
Metzgar RS; Lan MS; Kim YW; Koriwchak MJ; Mullins TD; Hollingsworth MA
Prog Clin Biol Res; 1989; 288():53-61. PubMed ID: 2717641
[No Abstract] [Full Text] [Related]
12. Breast cancer associated mucin: a review.
Segal-Eiras A; Croce MV
Allergol Immunopathol (Madr); 1997; 25(4):176-81. PubMed ID: 9269507
[TBL] [Abstract][Full Text] [Related]
13. High frequencies of functional tumor-reactive T cells in bone marrow and blood of pancreatic cancer patients.
Schmitz-Winnenthal FH; Volk C; Z'graggen K; Galindo L; Nummer D; Ziouta Y; Bucur M; Weitz J; Schirrmacher V; Büchler MW; Beckhove P
Cancer Res; 2005 Nov; 65(21):10079-87. PubMed ID: 16267034
[TBL] [Abstract][Full Text] [Related]
14. Th2-dominated antitumor immunity induced by DNA immunization with the genes coding for a basal core peptide PDTRP and GM-CSF.
Chu Y; Xia M; Lin Y; Li A; Wang Y; Liu R; Xiong S
Cancer Gene Ther; 2006 May; 13(5):510-9. PubMed ID: 16341143
[TBL] [Abstract][Full Text] [Related]
15. Mucin glycoproteins as tumor markers.
Feller WF; Henslee JG; Kinders RJ; Manderino GL; Tomita JT; Rittenhouse HG
Immunol Ser; 1990; 53():631-72. PubMed ID: 2100576
[TBL] [Abstract][Full Text] [Related]
16. Immunity to murine breast cancer cells modified to express MUC-1, a human breast cancer antigen, in transgenic mice tolerant to human MUC-1.
Carr-Brendel V; Markovic D; Ferrer K; Smith M; Taylor-Papadimitriou J; Cohen EP
Cancer Res; 2000 May; 60(9):2435-43. PubMed ID: 10811121
[TBL] [Abstract][Full Text] [Related]
17. Expression of native and deglycosylated colon cancer mucin antigens in normal and malignant epithelial tissues.
Yan PS; Ho SB; Itzkowitz SH; Byrd JC; Siddiqui B; Kim YS
Lab Invest; 1990 Nov; 63(5):698-706. PubMed ID: 2232715
[TBL] [Abstract][Full Text] [Related]
18. Human colon adenocarcinomas express a MUC1-associated novel carbohydrate epitope on core mucin glycans defined by a monoclonal antibody (A10) raised against murine Ehrlich tumor cells.
Medina M; Vélez D; Asenjo JA; Egea G; Real FX; Gil J; Subiza JL
Cancer Res; 1999 Mar; 59(5):1061-70. PubMed ID: 10070964
[TBL] [Abstract][Full Text] [Related]
19. Human B-cell immune response to the polymorphic epithelial mucin.
Rughetti A; Turchi V; Ghetti CA; Scambia G; Panici PB; Roncucci G; Mancuso S; Frati L; Nuti M
Cancer Res; 1993 Jun; 53(11):2457-9. PubMed ID: 8495404
[TBL] [Abstract][Full Text] [Related]
20. Human B cell immune response to selected epitopes of the polymorphic epithelial mucin (PEM) in cancer patients.
Nuti M; Rughetti A; Turchi V; Apollonj-Ghetti C; Scambia G; Frati L
In Vivo; 1993; 7(6B):645-7. PubMed ID: 7514896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
